Acadian Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-409,183
| Closed | -$7.58M | – | 1876 |
|
|
2023
Q3 | $7.58M | Buy |
409,183
+128,622
| +46% | +$2.38M | 0.03% | 339 |
|
|
2023
Q2 | $3.1M | Sell |
280,561
-129,032
| -32% | -$1.43M | 0.01% | 575 |
|
|
2023
Q1 | $5.5M | Buy |
409,593
+17,740
| +5% | +$238K | 0.02% | 437 |
|
|
2022
Q4 | $4.84M | Buy |
391,853
+291,417
| +290% | +$3.6M | 0.02% | 453 |
|
|
2022
Q3 | $1.4M | Buy |
100,436
+91,733
| +1,054% | +$1.28M | 0.01% | 720 |
|
|
2022
Q2 | $120K | Sell |
8,703
-101,110
| -92% | -$1.39M | ﹤0.01% | 1322 |
|
|
2022
Q1 | $1.79M | Sell |
109,813
-16,419
| -13% | -$267K | 0.01% | 694 |
|
|
2021
Q4 | $2.06M | Buy |
+126,232
| New | +$2.06M | 0.01% | 649 |
|
|
2021
Q3 | – | Sell |
-60,136
| Closed | -$1.2M | – | 2091 |
|
|
2021
Q2 | $1.2M | Buy |
+60,136
| New | +$1.2M | ﹤0.01% | 859 |
|
|
2021
Q1 | – | Sell |
-2,484
| Closed | -$61K | – | 2383 |
|
|
2020
Q4 | $61K | Buy |
+2,484
| New | +$61K | ﹤0.01% | 1890 |
|